INS and melanoma: She developed abrupt-onset, insulin-deficient diabetes presenting as diabetic ketoacidosis, characterized by undetectable C-peptide and negative islet cell autoantibodies, while undergoing adjuvant immunotherapy for stage IIIC melanoma.